RhBMP-2 vs. Autograft for Delayed Treatment of Critical Size Tibial Defects: A Multicenter Randomized Trial.
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Dibotermin alfa (Primary)
- Indications Fracture
- Focus Therapeutic Use
- 10 Jan 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
- 10 Jan 2017 Status changed from recruiting to discontinued.
- 29 Jun 2016 Planned primary completion date changed from 1 May 2016 to 1 Aug 2017.